|
 |
PatanolThis page contains recent news articles, when available, and an overview of Patanol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Patanol (when available) Used to treat allergic conjunctivitis (itching eyes), olopatadine inhibits the release of histamine from mast cells. It is a relatively selective histamine H1 antagonist that inhibits the in vivo and in vitro type 1 immediate hypersensitivity reaction including inhibition of histamine induced effects on human conjunctival epithelial cells. For the treatment of the signs and symptoms of allergic conjunctivitis. Mechanism Of Action: Olopatadine is a selective histamine H1 antagonist and binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Olopatadine is devoid of effects on alpha-adrenergic, dopamine and muscarinic type 1 and 2 receptors. News Articles on Olopatadine Novartis Has Eyes For Alcon - Jan 4, 2010 I've never worn contacts, but sometimes in the spring I've had to get prescriptions for Alcon's Patanol to use on days when pollen or whatever severely ... CNBC Barr Pharmaceuticals challenges patents on Alcon's Patanol - Oct 25, 2007 BOSTON (Thomson Financial) - Barr Pharmaceuticals Inc. Thursday said its Barr Laboratories subsidiary has initiated a challenge of Alcon Inc. patents ... Forbes Alcon's Eye Allergy Drug, PATANOL(R) Ophthalmic Solution, Approved in... - Jul 26, 2006 Alcon, Inc. (ACL) announced today that it has received approval from the Ministry of Health, Labor and Welfare in Japan to market its eye allergy drug, ... Genetic Engineering News - Genetic Engineering News (press release) Kyowa Hakko Shares Gain Most in 5 Years; Profit Jumps - Jul 30, 2007 Profit was bolstered by sales of anti-allergy medicines such as Allelock and Patanol, the Tokyo- based company said. Revenue rose 11 percent to 95 billion ... Bloomberg Patanol.(Relieves the red, itchy eyes often caused by allergies)(Drug... - Dec 1, 2005 Patanol should be used only for allergic conditions. It is not a remedy for irritation from contact lenses. When applying the eyedrops, be careful to avoid ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Patanol(R) (Olopatadine Hydrochloride Ophthalmic Solution), Approved ... - Jul 27, 2006 FORT WORTH, TX -- July 27, 2006 -- Alcon, Inc. announced that it has received approval from the Ministry of Health, Labor and Welfare in Japan to market its ... DG News Woman Charged With Unlicensed Optometry - Mar 10, 2007 She prescribed glasses, gave them medication samples and wrote prescriptions for Patanol eyedrops for allergy relief, the report states. ... Pay-Per-View - Tampa Tribune - ProQuest Archiver Event Brief of Q4 2004 Alcon Inc. Earnings Conference Call - Part 1. - Feb 10, 2005 Q&A Focus: Patanol QD, RETAANE, and ReSTOR. FINANCIAL DATA A. Key Data From Call 1. ... The Patanol is still on track for a 2006 approval. 4. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Alcon Sues Barr Over Generic Patanol Filing - Nov 5, 2007 Barr Laboratories recently submitted an abbreviated new drug application (ANDA) for generic Patanol with Paragraph IV certifications, prompting Alcon ... FDA news - FDA news (subscription) Kyowa Hakko "equal weight" - Mar 8, 2006 ...increased sales projections for Allelock, the analysts say. The domestic approval of Patanol has been delayed to July-September 2006, Morgan Stanley adds. newratings.com Alcon's First Quarter Sales Rise 14.3 Percent - Apr 25, 2007 Sales of allergy products, which include Patanol(R) ophthalmic solution and Pataday(TM) ophthalmic solution, rose 5.2 percent as strong sales from the ... Genetic Engineering News - Genetic Engineering News (press release) Alcon amends NDA for Patanase. - Oct 15, 2007 ...that used in Alcon's market-leading family of products for ocular allergies, which includes Pataday ophthalmic solution and Patanol ophthalmic solution. $4.95 - Pharma Marketletter - ECNext EDITED BRIEF - Apr 24, 2008 Major brands like TRAVATAN including DuoTrav, Patanol, AcrySof, OPTI-FREE, ... recent introduction of Patanol, Vigamox, and TRAVATAN in Japan have all ... $54.00 - Thomson StreetEvents - Alacra Store CAC test compares allergic conjunctivitis medications: conjunctival … - Sep 1, 2005 Seven antiallergy drugs share the market, with olopatadine (Patanol, ... However, only Patanol can treat the additional signs of allergy such as redness, ... Free with registration - Ophthalmology Times - AccessMyLibrary.com FINAL TRANSCRIPT - Apr 24, 2008 ...of Patanol, Vigamox, and Travatan in Japan have all contributed to this growth. ... Pataday has invigorated the category and the Patanol brand in the US and ... $54.00 - Thomson StreetEvents - Alacra Store Event Brief of Q1 2007 Alcon Inc. Earnings Conference Call - Final. - Apr 26, 2007 This performance was driven by new product introductions such as Patanol and ... Doing very well with the launch of Patanol in the competitive Japanese ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Merger and Acquisition Scenario - May 20, 2006 Patanol Once-A-Day (Olopatadine Hydrochloride); Patanol (Olopatadine Hydrochloride); Emadine (Emedastine Difumarate). Mast Cell Stabilizers ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 4, 2006 Patanol (Olopatadine Hydrochloride); Patanol Once-A-Day (Olopatadine Hydrochloride); Emadine (Emedastine Difumarate). Mast Cell Stabilizers ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 29, 2006 Patanol (Olopatadine Hydrochloride); Patanol Once-A-Day (Olopatadine Hydrochloride); Emadine (Emedastine Difumarate). Mast Cell Stabilizers ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Apr 22, 2006 Patanol Once-A-Day (Olopatadine Hydrochloride); Patanol (Olopatadine Hydrochloride); Emadine (Emedastine Difumarate). Mast Cell Stabilizers ... $250.00 - Revere Reports - Revere Alcon Manufacturing, Ltd. v. Apotex Inc., No. 1:06-cv-1642-RLY-TAB ( … - Mar 14, 2007 Apotex Canada developed the generic formula of Patanol® and was responsible for filing the ANDA. (Answer ¶ 24). Apotex Corp. ("Apotex USA") is a Delaware ... $2.95 - U.S. District Court, Southern District... - VersusLaw Merger and Acquisition Scenario - May 6, 2006 Target Products:. Patanol Once-A-Day (Olopatadine Hydrochloride); Patanol (Olopatadine Hydrochloride); Emadine (Emedastine Difumarate) $250.00 - Revere Reports - Revere Alcon's Second Quarter Sales Increase 12.8 Percent. - Jul 27, 2005 ...--Sales of allergy products, including Patanol(R) ophthalmic solution, rose 13.1 percent. Patanol(R) has maintained its number one share position in the US, ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Jan 27, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 20, 2006 Patanol Once-A-Day (Olopatadine Hydrochloride); Patanol (Olopatadine Hydrochloride); Emadine (Emedastine Difumarate). Mast Cell Stabilizers ... $250.00 - Revere Reports - Revere Alcon's Fourth Quarter Earnings Rise 39.9 Percent on 11.9 Percent... - Feb 9, 2005 ...--Sales of allergy products, including Patanol(R) ophthalmic solution, rose 12.9 percent. Patanol(R) has maintained its number one share position in the US, ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Mar 22, 2006 Patanol Once-A-Day (Olopatadine Hydrochloride); Patanol (Olopatadine Hydrochloride); Emadine (Emedastine Difumarate). Mast Cell Stabilizers ... $250.00 - Revere Reports - Revere Barr Laboratories challenges Alcon drug patents - Oct 29, 2007 Patanol is indicated for the treatment of allergic conjunctivitis. The drug had annual sales of approximately $320 million, based on IMS sales data ending ... OSN SuperSite Alcon's Second Quarter Sales Rise 17.9 Percent; Net Earnings Increase... - Jul 23, 2008 Sales of allergy products, which include Patanol(R) ophthalmic solution and Pataday(TM) ophthalmic solution, despite a mild allergy season in the US, ... Genetic Engineering News - Genetic Engineering News (press release) Event Brief of Q1 2006 Alcon Inc. Earnings Conference Call - Final. - Apr 25, 2006 The impact of this inventory may soften sales growth in 2Q06 for Patanol. 2. Observation About Pharmaceutical Business: ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Q4 2006 Alcon Inc. Earnings Conference Call - Part 1. - Feb 8, 2007 TobraDex and Patanol retained their market-leading positions with ... Continued share gains outside the US and the Japan launch lifted Patanol sales in the ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Experts explore possible treatments for seasonal allergic conjunctivit... - May 25, 2008 Dr. Rapuano: I think Patanol (olopatadine hydrochloride 0.1%, Alcon), ... I think it is better than Patanol. I think the extra concentration helps a lot. ... OSN SuperSite Event Brief of Q2 2006 Alcon Inc. Earnings Conference Call - Part 1. - Jul 25, 2006 As expected, Patanol experienced modest growth due to the impact of ... YTD Patanol was up about 11% globally and has pretty much maintained the Co. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Event Brief of Q2 2007 Alcon Inc. Earnings Conference Call - Final. - Jul 26, 2007 ...s recent global pharmaceutical launches like Patanol and Vegamox in Japan, DuoTrav in the EU and ... The success of the Patanol launch in Japan. 2. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Alcon's First Quarter Sales Rise 16.2 Percent; Net Income Increases... - Apr 23, 2008 Sales of allergy products, which include Patanol(R) ophthalmic solution and Pataday(TM) ophthalmic solution, rose 16.3 percent on market share gains for ... Genetic Engineering News - Genetic Engineering News (press release) Allergy drugs: the rise in allergies suggests complex causes. But … - Jun 15, 2006 Agents like olopatadine (Patanol, Alcon) are extremely safe and effective. ... Our favorite is Patanol, which appears to have an added benefit when combined ... Free with registration - Review of Optometry - AccessMyLibrary.com Mast Cell Stabilization and Anti-Histamine Effects of Olopatadine … - Oct 15, 2005 Jo review the currently available literature regarding one topical ophthalmic antiallergy agent, olopatadine (Patanol*), and its antihistaminic and mast ... RedOrbit Spectral-domain OCTs debut at AAO - Dec 1, 2006 Pataday is formulated with double the concentration of Patanol, which is administered ... Patanol, which has been on the market for more than a decade, ... OSN SuperSite Retail pharmacy is crazy.(Letters)(Letter to the Editor) - Feb 7, 2005 And to have to dispense a brand, or even nonessential drugs (Patanol, ... One customer I have gets a few bottles of Patanol at a time because she is ... Free with registration - Drug Topics - AccessMyLibrary.com Merger and Acquisition Scenario - Dec 27, 2008 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 29, 2008 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Alcon's Third Quarter Earnings Rise 52.2 Percent on 11.8 Percent... - Oct 19, 2005 ...--Sales of allergy products, including Patanol(R) ophthalmic solution, ... Patanol(R) solution has maintained its number one share position in the US, ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Oct 25, 2008 Pataday (Olopatadine Hydrochloride); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 6, 2008 Pataday (Olopatadine Hydrochloride); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere MM&M awards.(CMI-Communications Media, Inc.)(Baxter Bioscience)( … - Sep 1, 2005 CMI-Communications Media, Inc. and Alcon Laboratories for Patanol--Patanol 2005 NCO Media Plan. * Starcom USA and Aventis for Lantus--Lantus: Educate, ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Merger and Acquisition Scenario - May 24, 2008 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere January's winner ...(NAME THAT BRAND) | Article from Medical Marketing... - Mar 1, 2005 CMI-Communications Media, Inc. and Alcon Laboratories for Patanol--Patanol ... Healthcare Business Publication of the Year Sponsored by Communications Media ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Merger and Acquisition Scenario - Jun 14, 2008 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Q3 2007 Alcon Inc. Earnings Conference Call - Final. - Oct 25, 2007 This performance is occurring because the new product cycles for products like Patanol, Vigamox, Travatan and [sustained tears] that drove US sales growth ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com GSK hands CMI online HCP media.(MEDIA NOTEPAD)(Communications … - Mar 1, 2008 CMI-Communications Media, Inc. and Alcon Laboratories for Patanol--Patanol ... Healthcare Business Publication of the Year Sponsored by Communications Media ... Pay-Per-View - Medical Marketing & Media - HighBeam Research What's in the pipeline for ocular allergy? Recent developments... - Mar 15, 2007 Included in this class are olopatadine HCl (Patanol, Alcon), ketotifen fumarate ... It is a new formulation of Patanol (olopatadine 0.1%) with twice the ... Free with registration - Review of Optometry - AccessMyLibrary.com Apotex sued over eye drug. - Nov 17, 2006 Patanol is the top-seller in the US for the treatment of allergic conjunctivitis, a cause of itching, redness and tearing. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Merger and Acquisition Scenario - Jan 12, 2008 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Grocery Retail Online .com: Digital Marketplace for the grocery... - Sep 21, 2006 They produced a large animated eye for Alcon Pharmaceuticals to support the company's eye allergy medication, Patanol, at an industry tradeshow. ... Grocery Retail Online Alcon's Fourth Quarter Sales Rise 10.7 Percent - Feb 18, 2006 Sales of allergy products, including Patanol(R) ophthalmic solution, rose 18.3 percent. Patanol(R) maintained its number one share position in the US, ... businesswire.com … . (ACL) Receives Approval from Ministry of Health in Japan for... - Jul 26, 2006 Alcon, Inc. (NYSE: ACL) has received approval from the Ministry of Health, Labor and Welfare in Japan to market its eye allergy drug, PATANOL® (olopatadine ... StreetInsider.com - StreetInsider.com (subscription) 'Tis the season to sneeze - Nov 14, 2006 ...“They make some very good antihistamines like Patanol. ... Songe, 54, had used several medications like Patanol and Visine with only fair results. ... Muskogee Daily Phoenix Merger and Acquisition Scenario - Jul 28, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Communications Media Inc.(Update) | Article from Medical Marketing & ... - Aug 1, 2007 CMI-Communications Media, Inc. and Alcon Laboratories for Patanol--Patanol ... Healthcare Business Publication of the Year Sponsored by Communications Media ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Merger and Acquisition Scenario - Mar 31, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 3, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 22, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 27, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 29, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 19, 2006 Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride); Patanol Once-A-Day (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 24, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jun 30, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 10, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 27, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 29, 2006 Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride); Patanol Once-A-Day (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 1, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 24, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 22, 2007 Emadine (Emedastine Difumarate); Naphcon-A Eye Drops (Naphazoline Hydrochloride/Pheniramine Maleate); Patanol (Olopatadine Hydrochloride) ... $250.00 - Revere Reports - Revere NOSE-Y BODIES - ALLERGY SEASON NOTHING TO SNEEZE AT - May 10, 2005 Other, more heavy-duty eye drops, such as Patanol, require a prescription. * Nasal sprays: Flonase, Rhinocort and other steroid nasal sprays require a ... Pay-Per-View - New York Post - ProQuest Archiver Novartis to further strengthen its healthcare portfolio by acquiring... - Apr 7, 2008 ...products include TRAVATAN® solution for glaucoma, VIGAMOX® antibiotic solution for eye infections and the eye allergy solutions PATADAY® and PATANOL®. ... marketwire.com Tricks of the Trade Show - Apr 9, 2007 ...length while stating several times that client Alcon Laboratories' (ACL) Patanol eye drops are the No. 1 treatment for ocular allergic conjunctivitis. ... BusinessWeek You can live through grass-season allergies - Jun 10, 2005 For itchy, watery eyes use prescribed drops such as Patanol. Y If allergy symptoms persist, tell your doctor. You may be a candidate for allergy injections ... $2.95 - Detroit News - NewsBank Pink Eye| Eye Infection| Children Eye| Eye Care| Conjunctivitis - Jul 31, 2007 Allergic conjunctivitis can be treated with typical allergy medications, and topical drops, like Patanol and Alocril. Whatever be the cause, you must keep ... Oneindia Alcon gets OK for nasal spray - Apr 16, 2008 About the drug: The nasal spray has the same main ingredient — olopatadine hydrochloride — as Alcon's Patanol and Pataday drops for eye allergies. ... $2.95 - Fort Worth Star-Telegram - NewsBank Give optometrists larger role Report; Council suggests allowing them... - May 24, 2006 ...diseases like sties, and allergy-related problems that are often treated with prescription drops like Patanol at this time of year, McDonald said. ... Pay-Per-View - Toronto Star - ProQuest Archiver Fort Worth Star-Telegram : BRIEFLY - Nov 17, 2006 Alcon Inc., the world's largest eye-care company, sued Apotex Inc. on Wednesday to keep it from selling a generic version of the eye-allergy drug Patanol ... $2.95 - Fort Worth Star-Telegram - NewsBank Struggling parts of the world getting eye care from Alcon - - May 20, 2007 Finally last year, Alcon introduced its Patanol allergy eyedrops and its Vigamox antibiotic solution there. And the company is anticipating the go-ahead ... $2.95 - Fort Worth Star-Telegram - NewsBank Updates, advisories and surprises. - Oct 23, 2006 ...approval from the Food and Drug Administration to manufacture and sell a generic version of Alcon's allergy drug, Patanol ophthalmic solution. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Weather Channel Revamps Desktop Weather Tool - Mar 17, 2005 Advertisers include Hilton Garden Inn, Vonage, Walgreens, Holiday Inn Express, Celebrity Cruises, Sprint, LowerMyBills, The New York Times and Patanol. ... DM News Comparative Efficacy of Olopatadine 0.1% Ophthalmic Solution Versus … - Feb 25, 2005 Olopatadine 0.1% (Patanol[dagger] olopatadine hydrochloride ophthalmic solution 0.1%, Alcon Laboratories, Fort Worth, TX) was the first topical ocular ... RedOrbit Ventes nettes de Kyowa Hakko en hausse de 10,8 % pour les trois … - Jun 30, 2007 ...un agent antiallergique, et soutenues par les ventes de Patanol, une solution ophtalmique antiallergique lancée en octobre 2006. ... Boursier.com Hausse de 25,2 % du résultat d'exploitation intermédiaire de Kyowa … - Sep 30, 2007 Pendant ce temps, Patanol, une solution ophtalmique antiallergique lancée en octobre 2006, a pénétré son marché et contribué à la croissance des ventes. ... Boursier.com Alcon's Second Quarter Sales Rise 11.8 Percent - Jul 24, 2006 Sales of allergy products rose 1.2 percent as a decline in wholesaler inventories of Patanol(R) ophthalmic solution in the US led to slower reported sales ... Genetic Engineering News - Genetic Engineering News (press release) New formulations.( )(Bristol-Myers Squibb)(Brief Article) - Feb 7, 2005 The FDA has approved a 0.2% formulation/strength of Patanol (olopatadine hydrochloride ophthalmic solution), from Alcon Laboratories, Fort Worth, ... Free with registration - Drug Topics - AccessMyLibrary.com Kyowa Hakko's Original Anticancer Agent KW-2401(UCN-01) is Licensed … - Oct 4, 2006 ...and Olopatadine, indicated to relieve itching of the eye due to allergic conjunctivitis, and marketed in the US by Alcon as Patanol(R). ... japancorp.net Alcon Announces Leadership Change to Research and Development … - Mar 10, 2008 During his tenure, Alcon developed industry-leading therapies and devices including Patanol([R]) and Pataday([R]) for ocular allergies, Vigamox([R]) for ... Free with registration - Business Wire - AccessMyLibrary.com Alcon Amends NDA for Patanase(R) Nasal Spray. - Oct 10, 2007 ...in Alcon's market-leading family of products for ocular allergies, which includes PATADAY(TM) ophthalmic solution and PATANOL([R]) ophthalmic solution. ... Free with registration - Business Wire - AccessMyLibrary.com Kyowa Hakko Three-Month Net Sales up 10.8%; Raises Profit Forecasts - Jul 27, 2007 ...an antiallergic agent, and were supported by sales of Patanol, an antiallergic ophthalmic solution launched in October 2006. ... Genetic Engineering News - Genetic Engineering News (press release) Kyowa Hakko Nine-Month Operating Income up 17.5%.(Financial report) - Jan 29, 2007 ...launched in July 2006, and Patanol, an ophthalmic solution, which was launched in October 2006, rapidly penetrated its market and contributed to sales. ... Free with registration - Business Wire - AccessMyLibrary.com Alcon's Second Quarter Sales Rise 12.3 Percent - Jul 25, 2007 Sales of allergy products rose 16.6 percent due to the successful launches of Patanol(R) ophthalmic solution in Japan and Pataday(TM) ophthalmic solution in ... Genetic Engineering News - Genetic Engineering News (press release) Netherlands Corporate News - Sales Kyowa Hakko eerste kwartaal met … - Jul 31, 2008 However, sales of products such as Allelock, an antiallergic agent, Depakene, an anti-epileptic agent, and Patanol, an antiallergic ophthalmic solution, ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Kyowa Hakko Fiscal 2006 Operating Income up 20.2%. - Apr 27, 2007 ...and operating income are each forecast to increase as core products including Allelock continue to grow, and new product Patanol contributes to growth. ... Free with registration - Business Wire - AccessMyLibrary.com Alcon's First Quarter Sales Rise 8.1 Percent, Net Earnings Increase... - Apr 24, 2006 ...increased their inventories of Patanol(R) ophthalmic solution in advance of the allergy season by more than they did in last year's first quarter. ... Free with registration - Business Wire - AccessMyLibrary.com Most Dissatisfied With Allergy Meds: Survey - Mar 30, 2006 ...treatment options out there," Patel said. The study was funded by a grant from Alcon Laboratories Inc., which makes Patanol, an eye allergy medication. HealthCentral.com Netherlands Corporate News - Kyowa Hakko interim bedrijfsresultaten … - Oct 29, 2007 Meanwhile, Patanol, an antiallergic ophthalmic solution, launched in October 2006, has penetrated its market and contributed to sales growth. ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Analyze the Competitive Factors within the Ophthalmic Pharmaceuticals... - Nov 28, 2006 The new version of Patanol is highly anticipated for this reason as it offers a once-daily dosing. Similarly in the AMD market high dosing is compounded by ... Genetic Engineering News - Genetic Engineering News (press release) Brand Names/Synonyms: Patanol is also known by the following brand names and/or synonymsOlopatadine; Olopatadine Hydrochloride; Patanol Drug Category: Patanol is categorized under the following by the FDA: Anti-allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihistamines; Histamine H1 Antagonists; ATC:S01GX09 Dosage Forms: LIQUID Absorption: Ophthalmic use of olopatadine usually does not produce measurable plasma concentrations. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: Not Available |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |